Healthcare -
Biotechnology - NASDAQ - US
$ 9.2
-0.325 %
$ 1.34 B
Market Cap
-2.62
P/E
Price Target
Average
139.13%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
25.99%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
89bio, Inc.
Wall Street analysts predict an average 1-year price target for ETNB of $22 , with forecasts ranging from
a
low of
$12 to a high of $29 .
ETNB Lowest Price Target
Wall Street Target
12 USD
30.43%
ETNB Average Price Target
Wall Street Target
22 USD
139.13%
ETNB Highest Price Target
Wall Street Target
29 USD
215.22%
REVENUE FORECAST
Revenue Forecast Chart ETNB
EBIT FORECAST
EBIT Forecast Chart ETNB
NET INCOME FORECAST
Net Income Chart ETNB